Literature DB >> 7686921

Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.

F R Agbanyo1, J J Sixma, P G de Groot, L R Languino, E F Plow.   

Abstract

The role of thrombospondin, a multifunctional matrix glycoprotein, in platelet adhesion is controversial: both adhesive and antiadhesive properties have been attributed to this molecule. Because shear flow has a significant influence on platelet adhesion, we have assessed thrombospondin-platelet interactions both under static and flow conditions. The capacity of thrombospondin to support platelet adhesion depended upon its conformation. In a Ca(2+)-depleted conformation, such as in citrated plasma, thrombospondin was nonadhesive or antiadhesive as it inhibited platelet adhesion to fibrinogen, fibronectin, laminin, and von Willebrand factor by 30-70%. In a Ca(2+)-replete conformation, however, thrombospondin effectively supported platelet adhesion. Shear rate influenced this adhesion; percent surface coverage on thrombospondin increased from 5.4 +/- 0.3 at 0 s-1 to 41.5 +/- 6.7 at 1,600 s-1. In contrast to the extensive platelet spreading observed on fibronectin at all shear rates, platelet spreading on thrombospondin occurred only sporadically and at high shear rates. GPIa-IIa, GPIIb-IIIa, GPIV, and the vitronectin receptor, which are all proposed platelet receptors for thrombospondin, were not solely responsible for platelet adhesion to thrombospondin. These results suggest that thrombospondin may play a dual role in adhesive processes in vivo: (a) it may function in conjunction with other adhesive proteins to maintain optimal platelet adhesion at various shear rates; and (b) it may serve as a modulator of cellular adhesive functions under specific microenvironmental conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686921      PMCID: PMC293590          DOI: 10.1172/JCI116563

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Thrombospondin is synthesized and secreted by human osteoblasts and osteosarcoma cells. A model to study the different effects of thrombospondin in cell adhesion.

Authors:  P Clezardin; H Jouishomme; P Chavassieux; P J Marie
Journal:  Eur J Biochem       Date:  1989-05-15

2.  Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation.

Authors:  J L McGregor; B Catimel; S Parmentier; P Clezardin; M Dechavanne; L L Leung
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

3.  Alpha 2 beta 1 integrins from different cell types show different binding specificities.

Authors:  D Kirchhofer; L R Languino; E Ruoslahti; M D Pierschbacher
Journal:  J Biol Chem       Date:  1990-01-15       Impact factor: 5.157

4.  Interaction of thrombospondin with resting and stimulated human platelets.

Authors:  R Wolff; E F Plow; M H Ginsberg
Journal:  J Biol Chem       Date:  1986-05-25       Impact factor: 5.157

5.  An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin.

Authors:  J Lawler; R O Hynes
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

6.  The interaction of thrombospondin with platelet glycoprotein GPIIb-IIIa.

Authors:  J Karczewski; K A Knudsen; L Smith; A Murphy; V L Rothman; G P Tuszynski
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

7.  Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins.

Authors:  B S Coller; J H Beer; L E Scudder; M H Steinberg
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

8.  Thrombospondin promotes platelet aggregation.

Authors:  G P Tuszynski; V L Rothman; A Murphy; K Siegler; K A Knudsen
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

9.  Thrombospondin modulates focal adhesions in endothelial cells.

Authors:  J E Murphy-Ullrich; M Höök
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

10.  Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors.

Authors:  J Lawler; R Weinstein; R O Hynes
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  7 in total

1.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Role of platelet adhesion in homeostasis and immunopathology.

Authors:  D N Männel; G E Grau
Journal:  Mol Pathol       Date:  1997-08

3.  Thrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in mice.

Authors:  Prem Prakash; Paresh P Kulkarni; Anil K Chauhan
Journal:  Blood       Date:  2014-10-24       Impact factor: 22.113

Review 4.  Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria.

Authors:  Ulrike Binsker; Thomas P Kohler; Sven Hammerschmidt
Journal:  J Innate Immun       Date:  2019-02-27       Impact factor: 7.349

5.  Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets.

Authors:  Analia Garcia; Todd M Quinton; Robert T Dorsam; Satya P Kunapuli
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

6.  Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.

Authors:  Jeff S Isenberg; Martin J Romeo; Christine Yu; Christine K Yu; Khauh Nghiem; Jude Monsale; Margaret E Rick; David A Wink; William A Frazier; David D Roberts
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

7.  Increased platelet deposition on atherosclerotic coronary arteries.

Authors:  G H van Zanten; S de Graaf; P J Slootweg; H F Heijnen; T M Connolly; P G de Groot; J J Sixma
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.